CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab
Raghu Ganesh, Martinez Fernando J., Brown Kevin K., Costabel Ulrich, Cottin Vincent, Wells Athol U., Lancaster Lisa, Gibson Kevin F., Haddad Tarik, Agarwal Prasheen, Mack Michael, Dasgupta Bidisha, Nnane Ivo P., Flavin Susan K., Barnathan Elliot S.
Source: Eur Respir J 2015; 46: 1740-1750
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Raghu Ganesh, Martinez Fernando J., Brown Kevin K., Costabel Ulrich, Cottin Vincent, Wells Athol U., Lancaster Lisa, Gibson Kevin F., Haddad Tarik, Agarwal Prasheen, Mack Michael, Dasgupta Bidisha, Nnane Ivo P., Flavin Susan K., Barnathan Elliot S.. CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab. Eur Respir J 2015; 46: 1740-1750
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: